FDA
-
-
-
-
-
-
-
SINTX Technologies completes first surgery using FDA-cleared foot implant
-
-
-
-
-
-
-
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
-
-
-
-
-
-
-
SINTX Technologies reports silicon nitride shows antiviral activity
-
-
-
-
-
-
-
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors
-
-
-
-
-
-
-
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
-
-
-
-
-
-
-
SINTX ANNOUNCES SUCCESSFUL FDA 510(k) PRE-SUBMISSION MEETING FOR SILICON NITRIDE-PEEK COMPOSITE SPINE IMPLANTS
-
-
-
-
-
-
-
SINTX Technologies Acquires Technology Assessment and Transfer, Inc.
-
323,324 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

